EIM
XERS icon

Essex Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

Essex Investment Management’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.34M Buy
747,769
+13,237
+2% +$87.8K 0.69% 46
2025
Q4 		$5.77M Sell
734,532
-15,502
-2% -$122K 0.88% 35
2025
Q3 		$6.11M Buy
750,034
+24,260
+3% +$161K 0.93% 29
2025
Q2 		$3.39M Sell
725,774
-4,670
-0.6% -$21.4K 0.62% 55
2025
Q1 		$4.01M Buy
730,444
+255,489
+54% +$1.03M 0.84% 32
2024
Q4 		$1.61M Buy
+474,955
New +$1.53M 0.29% 129
2020
Q3 		– Sell
-255,530
Closed -$680K – 506
2020
Q2 		$680K Buy
+255,530
New +$890K 0.11% 227

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Essex Investment Management's XERS Position: Q1 2026 in Review

Essex Investment Management increased its Xeris Biopharma Holdings (XERS) stake by 1.8% in Q1 2026, buying an estimated $87.8K and bringing the position to 747,769 shares worth $4.34M. The position accounts for 0.69% of the portfolio, ranked #46.

Essex Investment Management first reported a position in XERS in Q2 2020 and has held it in 7 quarters since. The position peaked at $6.11M in Q3 2025. 237 funds tracked by Wall St. Rank hold XERS as of Q1 2026.

  • Essex Investment Management held 747,769 shares of Xeris Biopharma Holdings worth $4.34M as of Q1 2026.
  • Essex Investment Management bought 13,237 Xeris Biopharma Holdings shares in Q1 2026, an estimated $87.8K.
  • Xeris Biopharma Holdings made up 0.69% of Essex Investment Management's portfolio in Q1 2026, its #46 holding.
  • Essex Investment Management first reported a position in Xeris Biopharma Holdings in Q2 2020 and has held it in 7 quarters since.
  • Essex Investment Management's Xeris Biopharma Holdings position peaked at $6.11M in Q3 2025.
  • 237 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.